The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

Pulmonary hypertension (PH) is a rare, progressive, debilitating condition characterised by elevated pulmonary artery ...

The US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog ...

The FDA also approved treprostinil (Yutrepia) inhalation powder for patients with pulmonary arterial hypertension and ...

Like other inhaled prostaglandins, YUTREPIA may cause acute bronchospasm. Patients with asthma or chronic obstructive pulmonary disease (COPD), or other bronchial hyperreactivity, are at increased ...

Keros Therapeutics Inc (NASDAQ:KROS) released topline data from the TROPOS Phase 2 trial of cibotercept (KER-012) in ...

A complex surgery was successfully performed on a Tamil Nadu native whose oxygen level had dangerously dropped due to blood clots in the arteries of the lungs.

Researchers used PET/MRI to detect otherwise invisible inflammation. Less clear is how this might influence patient care.

Cannabis use among older Americans has climbed dramatically, with 7% of adults 65 and older now reporting recent use. This ...

The spring meeting of the Irish Society for Rheumatology brought together experts from across Ireland and the UK to highlight ...

Researchers warn of increased cannabis use among older US adults, as experts link it to health risks and complications in chronic disease management.